Early predictors of mortality for moderate to severely ill patients with Covid-19 in Erbil city

Taha Khudhur  Ahmed; Halgurd Fathulla  Ahmed; Haval Faris  Mohammed

doi:10.56056/amj.2023.210

Authors

Taha Khudhur Ahmed M.B.Ch.B., trainee at Kurdistan higher council for medical specialties; West Emergency Hospital-Erbil-Kurdistan region/Iraq
Halgurd Fathulla Ahmed M.B.Ch.B., F.I.B.M.S; Assistant Professor in Internal Medicine-Director of training Kurdistan higher council for medical specialties-Erbil-Kurdistan region/Iraq
Haval Faris Mohammed M.B.Ch.B, FKBMS_EM; Emergency Medicine Specialist; West Emergency Hospital-Erbil-Kurdistan region/Iraq

DOI:

https://doi.org/10.56056/amj.2023.210

Keywords:

Corona infections disease, Dyspnea, Hypoxia, Mortality, Severity of COVID-19

Abstract

Background & Objectives: COVID-19 disease represents a major burden on national health institutes. The aim of study is to figure out the parameters that can predict the mortality in moderate to severely ill Covid-19patients. That enable us to predict the course of the disease and reduce the mortality of Covid-19 patients.

Methods: A prospective cross-sectional study carried out in West Emergency Hospital in Erbil city-Kurdistan region/Iraq from February to August 2021onsample of one hundred patients with positive real-time polymerase chain reaction.The patients were followed up from their admission to hospital until their discharge alive or dead.Their data were collected by direct interview with them or from their relatives or saved records in hospital and fulfilled in a prepared questionnaire.

Results: The mortality rate of hospitalized patients with moderate to severe Corona infections diseasewas (44%). The older age of patients was significantly related to higher mortality rate. The patients presented with dyspnea (51.4%), hypertension (57.1%) and renal failure were significantly associated with higher mortality rates. High respiratory rate (>25 bpm), low oxygen saturation (<88%), and high C-reactive protein level (>59) were accompanied with higher mortality rates. These results were statistically significant.

Conclusion: The early predictors of mortality in patients with moderate to severe Corona infections disease were elderly age, dyspnea, co-morbidity with hypertension and renal failure, high respiratory rate, low oxygen saturation and elevated levels of C-reactive protein.

Downloads

Download data is not yet available.

References

Peeri NC, Shrestha N, Rahman MS, et al. The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: What lessons have we learned? Int J Epidemiol 2020; 49(1): 717–26.

Worldometer Coronavirus Update: Cases and Deaths from COVID-19 Virus Pandemic. 2022. Available from: https://www.worldometers.info/coronavirus/.

(COVID-19), What the KRG is doing 2020. Available from: https://gov.krd/coronavirus-en/situation-update/.

Lauer SA, Grantz KH, Bi Q. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020; 172(9):577-82.

Guan WJ, Ni ZY, Hu Y. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382(18):1708-20.

Wu, JT, Leung K, et al. Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nat Med. 2020; 26(1): 506–10.

Ng OT, Marimuthu K, Chia PY, et al. SARS-CoV-2 Infection among Travelers Returning from Wuhan, China. N Engl J Med. 2020; 382(1): 1476–8.

Bi Q, Wu Y, Mei S, et al. Epidemiology and transmission of COVID-19 in 391 cases and 1286 of their close contacts in Shenzhen, China: A retrospective cohort study. Lancet Infect Dis. 2020; 20(1): 911–9.

World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (?2019-nCoV)? infection is suspected: interim guidance. 2020. https://apps.who.int/iris/handle/10665/330893.

National Health and Health Commission of NPC Interim Guidance for Novel Coronavirus Pneumonia (Trial Implementation of Revised Eigthth Edition). 2020. Available online: http://www.gov.cn/zhengce/zhengceku/2020-08/19/content_5535757.htm.

Zhang J, Wang X, Jia X, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020; 26(1): 767–72.

Jin JM, Bai P, He W, et al. Gender Differences in Patients with COVID-19: Focus on Severity and Mortality. Front Public Health. 2020; 8(1): 152-3.

Verity R, Okell LC, Dorigatti I, et al. Estimates of the severity of coronavirus disease 2019: A model-based analysis. Lancet Infect Dis. 2020; 20(1): 669–77.

Pan A, Liu L, Wang C, et al. Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA. 2020; 323(1): 1915-6.

Sun Y, Dong Y, Wang L. Characteristics and prognostic factors of disease severity in patients with COVID-19: The Beijing experience. J Autoimmun. 2020; 112(1):102473-4.

Mo P, Xing Y, Xiao Y. Clinical Characteristics of Refractory Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2021; 73(11): e4208-13.

Robilotti EV, Babady NE, Mead PA. Determinants of Severity in Cancer Patients with COVID-19 Illness. Preprint. MedRxiv. 2020;.20(1):863-4.

Bornstein SR, Rubino F, Khunti K. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020; 8(6):546-50.

Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62354 COVID-19 cases in the USA. Lancet Psychiatry. 2021; 8(1): 130–40.

Gross O, Moerer O, Weber M, Huber TB, Scheithauer S. COVID-19-associated nephritis: early warning for disease severity and complications? Lancet. 2020; 395(10236): e87-8.

Louapre C, Collongues N, Stankoff B. Clinical Characteristics and Outcomes in Patients with Coronavirus Disease 2019 and Multiple Sclerosis. JAMA Neurol. 2020; 77(9):1079-88.

Zhang X, Tan Y, Ling Y, et al. Viral and host factors related to the clinical outcome of COVID-19. Nat. Cell Biol. 2020; 583(1): 437–40.

Fajnzylber J, Regan J, Coxen K, et al. SARS-CoV-2 viral load is associated with increased disease severity and mortality. Nat Commun. 2020; 11(1): 1–9.

Li K, Wu J, Wu F, et al. The Clinical and Chest CT Features Associated with Severe and Critical COVID-19 Pneumonia. InvestigRadiol. 2020; 55(1): 327–31.

Wu J, Li W, Shi X, et al. Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19). J Intern Med. 2020; 288(1): 128–38.

Domingo JL, Rovira J. Effects of air pollutants on the transmission and severity of respiratory viral infections. Environ Res. 2020; 187(1): 109650-1.

Walker PG, Whittaker C, Watson O, et al. Report 12—The Global Impact of COVID-19 and Strategies for Mitigation and Suppression. 2020. Available from: https://www.imperial.ac.uk/mrc-global-infectious-diseaseanalysis/covid-19/report-12-global-impact-covid-19/.

Leung K, Wu JT, Liu D, Leung GM. First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: A modelling impact assessment. Lancet. 2020; 395(1): 1382–93.

Choi YJ, Park JY, Lee HS, et al. Variable effects of underlying diseases on the prognosis of patients with COVID-19. PLoS ONE. 2021; 16(7): e0254258.

Srinivasan BS. Diagnosis and treatment protocol for novel coronavirus pneumonia (Version 7) Chin Med J. 2020; 133:1087–95.

Nguyen NT, Chinn J, De Ferrante M, et al. Male gender is a predictor of higher mortality in hospitalized adults with COVID-19. PLoS One. 2021; 16(7):e0254066.

Mohammed IA, Ali AH, Al-Shenaty JA. Clinical course and disease outcomes in hospitalized patients with 2019 novel corona virus disease at Ibn- Al Khateeb Hospital in Baghdad, Iraq. JFac Med Baghdad. 2020; 62 (3): 48-59.

Mammen JJ, Kumar S, Thomas L. Factors associated with mortality among moderate and severe patients with COVID-19 in India: a secondary analysis of a randomised controlled trial. BMJ Open. 2021; 11(1): e050571.

Aksel G, ?slam MM, Alg?n A, et al. Early predictors of mortality for moderate to severely ill patients with Covid-19. Am J Emerg Med. 2021; 45(1):290-6.

Chen J, Liu Y, Qin J. Hypertension as an independent risk factor for severity and mortality in patients with COVID-19: a retrospective study. Postgrad Med J. 2021; 1(1):4067-14.

Pya Y, Bekbossynova M, Gaipov A, et al. Mortality predictors of hospitalized patients with COVID-19: Retrospective cohort study from Nur-Sultan, Kazakhstan. PLoS ONE. 2021; 16(12): e0261272. Available from: https://doi.org/10.1371/journal. pone.0261272.

Sepandi M, Taghdir M, Alimohamadi Y, Afrashteh S, Hosamirudsari H. Factors Associated with Mortality in COVID-19 Patients: A Systematic Review and Meta-Analysis. Iran J Public Health. 2020; 49(7):1211-21.

Nlandu Y, Mafuta D, Sakaji J. Predictors of mortality in COVID-19 patients at Kinshasa Medical Center and a survival analysis: a retrospective cohort study. BMC Infect Dis. 2021; 21(1): 1272-3. Available from: https://doi.org/10.1186/s12879-021-06984-x.

Mukhtar A, Rady A, Hasanin A. Admission SpO2 and ROX index predict outcome in patients with COVID-19. Am J Emerg Med. 2021; 50(1):106-10.

Xie J, Covassin N, Fan Z. Association Between Hypoxemia and Mortality in Patients With COVID-19. Mayo Clin Proc. 2020; 95(6):1138-47.

Timpau AS, Miftode RS, Petris AO, et al. Mortality Predictors in Severe COVID-19 Patients from an East European Tertiary Center: A Never-Ending Challenge for a No Happy Ending Pandemic. J Clin Med. 2022; 11(1): 58-9. Available from: https://doi.org/10.3390/jcm11010058.